Your browser doesn't support javascript.
loading
Diroximel fumarate (DRF) in patients with relapsing-remitting multiple sclerosis: Interim safety and efficacy results from the phase 3 EVOLVE-MS-1 study.
Naismith, Robert T; Wolinsky, Jerry S; Wundes, Annette; LaGanke, Christopher; Arnold, Douglas L; Obradovic, Dragana; Freedman, Mark S; Gudesblatt, Mark; Ziemssen, Tjalf; Kandinov, Boris; Bidollari, Ilda; Lopez-Bresnahan, Maria; Nangia, Narinder; Rezendes, David; Yang, Lili; Chen, Hailu; Liu, Shifang; Hanna, Jerome; Miller, Catherine; Leigh-Pemberton, Richard.
Affiliation
  • Naismith RT; Washington University School of Medicine, St. Louis, MO, USA.
  • Wolinsky JS; Department of Neurology, McGovern Medical School, The University of Texas Health Science Center at Houston (UTHealth), Houston, TX, USA.
  • Wundes A; Department of Neurology, University of Washington Medical Center, Seattle, WA, USA.
  • LaGanke C; North Central Neurology Associates, Cullman, AL, USA.
  • Arnold DL; Montreal Neurological Institute, McGill University, Montreal, QC, Canada/NeuroRx Research Inc., Montreal, QC, Canada.
  • Obradovic D; Department of Neurology, Military Medical Academy, Belgrade, Serbia.
  • Freedman MS; University of Ottawa and the Ottawa Hospital Research Institute, Ottawa, ON, Canada.
  • Gudesblatt M; South Shore Neurologic Associates, Patchogue, NY, USA.
  • Ziemssen T; Center of Clinical Neuroscience, Carl Gustav Carus University Hospital, Dresden, Germany.
  • Kandinov B; Alkermes Inc, Waltham, MA, USA.
  • Bidollari I; Alkermes Inc, Waltham, MA, USA.
  • Lopez-Bresnahan M; Alkermes Inc, Waltham, MA, USA.
  • Nangia N; Alkermes Inc, Waltham, MA, USA.
  • Rezendes D; Alkermes Inc, Waltham, MA, USA.
  • Yang L; Biogen, Cambridge, MA, USA.
  • Chen H; Biogen, Cambridge, MA, USA.
  • Liu S; Biogen, Cambridge, MA, USA.
  • Hanna J; Biogen, Maidenhead, UK.
  • Miller C; Biogen, Cambridge, MA, USA.
  • Leigh-Pemberton R; Alkermes Inc, Waltham, MA, USA.
Mult Scler ; 26(13): 1729-1739, 2020 11.
Article in En | MEDLINE | ID: mdl-31680631

Full text: 1 Database: MEDLINE Main subject: Multiple Sclerosis, Relapsing-Remitting / Multiple Sclerosis Limits: Humans Language: En Journal: Mult Scler Journal subject: NEUROLOGIA Year: 2020 Type: Article Affiliation country: United States

Full text: 1 Database: MEDLINE Main subject: Multiple Sclerosis, Relapsing-Remitting / Multiple Sclerosis Limits: Humans Language: En Journal: Mult Scler Journal subject: NEUROLOGIA Year: 2020 Type: Article Affiliation country: United States